Conversely, only half of the metastatic uterine cervix cancer tumors express GRPR at the same level of immunoreactivity; however, such a finding remains exploratory as there were only six metastatic sites sampled and none with a paired primary tumor in our study. The gene discussed is GRPR; the disease is cervical cancer.